FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, precisely to cellular biology and experimental oncology and can be used for development of new methods aimed at antitumorigenesis. Human chorionic gonadotropin (HCG) is used for stimulation of pathological process and disorganisation of cell carcinoma culture of throat Hep-2.
EFFECT: invention allows effecting turmoral Hep-2 cell lines, excluding lymphocytic mediation, as well as hormone effect through the specific receptors with having signs of tumor degradation in the condition of cell culture.
2 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR INHIBITION OF MITOTIC ACTIVITY OF PLISS'S LYMPHOSARCOMA CELLS | 2004 |
|
RU2263514C1 |
| AGENT FOR INHIBITION OF PLISS'S LYMPHOSARCOMA GROWTH | 2004 |
|
RU2263513C1 |
| METHOD FOR OBTAINING AUTOLOGOUS REGULATORY T-LYMPHOCYTES BY EX VIVO CULTIVATION IN PRESENCE OF HUMAN CHORIONIC GONADOTROPIN | 2022 |
|
RU2791738C1 |
| METHOD FOR STIMULATING HEPATIC TISSUE REPAIR | 1999 |
|
RU2185835C2 |
| MEDICAL PRODUCT REDUCING CONTENT OF POORLY DIFFERENTIATED CELLS AND INCREASING CONTENT OF HIGHLY DIFFERENTIATED CELLS IN NON-SPECIFIC INVASIVE BREAST CARCINOMA | 2019 |
|
RU2743710C1 |
| AGENT FOR NORMALIZING OF CD4 T-LYMPHOCYTE LEVEL IN PLISS LYMPHOSARCOMA | 2006 |
|
RU2316338C1 |
| COMPOSITION FOR INCREASING CONTENT OF HIGHLY DIFFERENTIATED CELLS IN BREAST ADENOCARCINOMA | 2018 |
|
RU2697199C1 |
| METHOD OF STIMULATION OF HEPATIC TISSUE REGENERATION | 1997 |
|
RU2134582C1 |
| AGENT REDUCING RELATIVE CONTENT OF LOW-DIFFERENTIATED CELLS AND INCREASING RELATIVE CONTENT OF HIGH-DIFFERENTIATED CELLS IN INVASIVE MAMMARY GLAND CARCINOMA OF NON-SPECIFIC TYPE | 2022 |
|
RU2786528C1 |
| METHOD OF NEOGENESIS PROCESSES CORRECTION | 2007 |
|
RU2350340C1 |
